FormWeb • boceprevir

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

boceprevir

boceprevir

Restricted Miscellaneous Programs
Restricted Victrelis --> Restricted to continuation of therapy.

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Victrelis	CAPSULE, ORAL	200 mg

Comments:

Victrelis medication guide

VICTRELIS is a new oral protease inhibitor for the treatment of hepatitis C. It must be scheduled every 8 hours and administered with food. Adverse reactions can occur, including hematological reactions. In addition, drug interactions can occur with the CYP-3A4 system. VICTRELIS is an automatic pharmacy consult to assure proper dosing and diet schedule, drug interaction screening, and adverse drug reaction monitoring.

VICTRELIS is classified as a formulary agent, restricted to the continuation of therapy. Patient may use home supply if available. Therapy initiation should be deferred to the outpatient setting where a financial management plan can be developed for the patient.

Reviewed: September 27, 2011

Last updated: Dec. 28, 2017

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.